Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Project Updates and Milestones news
31 July 2026
Sasol and partners commission 2 kW HySA PEM electrolyser in Sasolburg
A 2 kW PEM electrolyser will be used for testing, skills development and system integration under variable renewable power, supporting localisation and PGM beneficiation.
31 July 2026
KazMunayGas and CITIC Group deepen strategic partnership
Joint venture KBM produced 1.018 MMt in H1; Coastal Zone drilling and reserves expanded; CASPI BITUM upgraded to 1.5 MMtpa refining and 750 Ktpa bitumen output.
31 July 2026
KazMunayGas and Sinopec review joint projects
2D (900 km) and 3D (300 km2) seismic work ahead of a 7,000 m ultra‑deep well; 1.25 MMtpa PE plant >34% complete; Aktobe output target 800 Kt by 2028; CCUS working group proposed.
31 July 2026
Novo Nordisk: ZEUS phase 3 finds no MACE reduction with ziltivekimab
Ziltivekimab lowered free IL‑6 and hsCRP but did not reduce cardiovascular events; safety similar to placebo except for more serious infections; related trials continue with H1 2027 readouts.
31 July 2026
LyondellBasell Q2 2026 earnings
EBITDA $1.3bn ($2.1bn ex-items); net income $0.6bn ($1.4bn ex-items); completed European asset divestiture; $500m Cash Improvement Plan target by end‑2026.
31 July 2026
Moeve H1 2026: €1.2bn Clean CCS EBITDA; 69% of H1 capex to energy transition in Spain
Net income €458m, capex €605m and operating cash flow €762m; leverage fell to 1.2x; groundbreaking for 300 MW Andalusian Green Hydrogen Valley on Sept 17; Galp merger talks continue.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
31 July 2026
Chugai files for Enspryng indication to prevent relapses in MOGAD in Japan
Regulatory submission seeks approval of satralizumab to prevent relapse in MOG antibody‑associated disease after Phase III showed a 68% risk reduction.
31 July 2026
OMV Petrom Group H1 2026 results
Clean CCS Operating Result 3 bn lei; net income 1.8 bn lei; CAPEX 3.7 bn lei; contribution to state budget 10.2 bn lei; Neptun Deep on track for first gas in 2027.
31 July 2026
Umicore H1 2026 results
Adj. EBITDA +33% to €577m and margin 30.2%; revenues €1.9bn; Free Operating Cash Flow €295m; guidance upgraded to slightly above €1bn adj. EBITDA for FY2026.
31 July 2026
Shell to sell BG Cyprus Ltd to MOL Group for up to $720 million
35% non-operated stake in Cyprus Block 12 (Aphrodite); produced gas to be sold to EGAS; completion expected early 2027, subject to approvals.
31 July 2026
OMV Q2 2026: Clean CCS operating result €1,706m
Strong cash flow and low leverage; all segments profitable. Chemicals lifted by Borouge International closing and higher olefin/polyolefin prices.
31 July 2026
Holcim: H1 recurring EBIT +11.5% organically, guidance upgraded
Net sales +5.2% organic H1; recurring EBIT margin 18.1%; closed Xella and Cementos Pacasmayo; FY2026 guidance raised to ~5% sales and ~10% recurring EBIT growth.
31 July 2026
MCG Group Q1 consolidated results (FY Mar 2027)
Sales rose 14% to ¥1,004.2bn; core operating income doubled to ¥114.1bn. Semiconductor demand, higher prices, FX and Middle East-driven naphtha effects boosted performance.
31 July 2026
Borouge Plc delivers 23% QoQ net profit rise despite Ruwais incident
Restored full production after 5 April incident; shipped all available volumes plus inventory; realised prices rose 53% QoQ; margins squeezed by higher logistics and propylene costs.
30 July 2026
KMG and CNOOC discuss expanding cooperation
Reviewed joint drilling and tech projects, the Zhylyoi exploration (400 lin. km 2D reprocessing; 400 km2 3D seismic due by end‑2026) and 50/50 financing.
30 July 2026
Huntsman Q2 2026 results and Olin merger update
Q2 net loss $6M, adjusted EBITDA $120M; free cash flow used $90M; signed all‑stock merger with Olin; stockholder vote Aug 25, 2026.
30 July 2026
Johnson & Johnson: FDA Priority Review for potential first-in-class subcutaneous RYBREVANT FASPRO in recurrent/metastatic HNSCC
OrigAMI-4 showed 42% response rate with >1/3 complete responses; FDA review shortened to ~6 months; drug targets EGFR and MET and is co-formulated with hyaluronidase.
30 July 2026
BASF: Mix of technologies required to recycle engineering plastics
Engineering plastics need tailored recycling—mechanical, solvent, depolymerisation or thermochemical—selected by waste composition; loopamid commercial plant began in early 2025; sorting and regulation are crucial.
30 July 2026
TechnipFMC Q2 2026 results
Revenue $2.76bn; net income $363m; Subsea inbound $2.5bn; cash from operations $548m and free cash flow $488m; $440m returned to shareholders.
30 July 2026
Exolum takes minority stake in SeaSeaS Amsterdam CO₂ export terminal
Open-access multimodal terminal to handle up to 3.5 million tonnes CO₂/year, operational by 2030, linking inland emitters to North Sea permanent storage by vessel, rail, road or pipeline.
30 July 2026
Takeda Q1 FY2026 results and ORZEYFUL China approval
Solid quarter: revenue +10.2% AER; adjusted free cash flow JPY 68.6bn; launch prep for ORZEYFUL, rusfertide and zasocitinib; FY2026 outlook unchanged.
30 July 2026
Arkema Q2 2026 results
EBITDA +7.4% YoY to €391m and margin 16.1%; organic sales +3.2%; raw-material cost spike prompted pricing moves; FY‑26 EBITDA guidance slightly above last year at constant FX.
30 July 2026
Heidelberg Materials reports Q2 revenue €6.04bn and narrows 2026 RCO range
Revenue rose 6% to €6,044m and RCO to €1,086m. Strategic acquisitions in North America and Turkey; new 1.25 Mt kiln in France and Padeswood CCS on schedule.
30 July 2026
Vopak H1 2026 results: raises FY outlook and declares EUR 0.72 interim dividend
Raised FY2026 proportional EBITDA and operating free cash flow guidance; first semi‑annual interim dividend of EUR 0.72; major growth and BESS investments progressing.
30 July 2026
bp starts up Atlantis Major Facility Expansion
Adds two subsea water‑injection wells to boost reservoir pressure, unlocking ~10,000 boe/d gross peak and extending the Atlantis field’s producing life.
30 July 2026
Veolia wins 20-year contract to modernize Cúcuta water infrastructure
Long-term contract to upgrade water and sanitation for 866,000 residents, cut losses below 30%, and deploy leak detection and network renewal.
30 July 2026
WACKER Q2 2026 results — PACE savings and pension effect boost earnings
Q2 sales €1.52bn; EBITDA €211m aided by cost cuts and a €36.7m pension revaluation; net income includes €243m from Siltronic sale; full‑year guidance adjusted.
30 July 2026
Technip Energies H1 2026: €12.7bn order intake and €25bn backlog
Order intake €12.7bn raised backlog to €25bn; H1 revenue €3.7bn and EBITDA €212m after provisions; Project Delivery margin guidance reduced for 2026.
30 July 2026
MAIRE: H1 2026 results — €3.7bn revenues, strong order intake and M&A in Nextchem
Revenues +6.9% to €3.68bn; EBITDA +14.7% to €266.2m; H1 order intake €7.2bn, backlog €16.3bn; Nextchem buys Ballestra and 70% of ETEK.
30 July 2026
Evonik‑licensed Leshan H₂O₂ megaplant (Fuhua) starts production
200 kt/yr industrial H₂O₂ plant began operations on 18 June 2026; will sell to the merchant market and supply a JV for further purification into specialty grades.
Next →
